LITS CIK: 1262104

Lite Strategy, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
40.7
FY23:
–
FY24:
–
FY25:
–
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−75.5
FY23:
−36.8
FY24:
14.5
FY25:
−17.5
FY26:
−66.6
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
−17.6
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−54.5
FY23:
−31.8
FY24:
17.8
FY25:
−15.9
FY26:
−71.2
(positive)
Change from FY22 to FY26
millions USD
FY22:
−54.5
FY23:
−31.8
FY24:
17.8
FY25:
−15.9
FY26:
−71.2

All amounts in millions USD Data sources:SEC EDGARTwelve Data